Heart Rhythm
Volume 6, Issue 3, Supplement , Pages S36-S44 , March 2009

Evidence regarding clinical use of microvolt T-wave alternans

  • Stefan H. Hohnloser, MD

      Affiliations

    • Division of Cardiology, Department of Medicine, J. W. Goethe University, Frankfurt, Germany
    • Corresponding Author InformationAddress reprint requests and correspondence: Dr. Stefan H. Hohnloser, Division of Cardiology, Department of Medicine, J. W. Goethe University, Theodor-Stern-Kai 7 Building 23, Frankfurt, 60590, Germany
    • ,
  • Takanori Ikeda, MD

      Affiliations

    • 2nd Department of Internal Medicine, Kyorin University, Tokyo, Japan
    • ,
  • Richard J. Cohen, MD, PhD

      Affiliations

    • Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, Massachusetts

References 

  1. Klingenheben T, Zabel M, D'Agostino RB, et al. Predictive value of T-wave alternans for arrhythmic events in patients with congestive heart failure. Lancet. 2000;356:651–652
  2. Ikeda T, Saito H, Tanno K, et al. T-wave alternans as a predictor for sudden cardiac death after myocardial infarction. Am J Cardiol. 2002;89:79–82
  3. Kitamura H, Ohnishi Y, Okajima K, et al. Onset heart rate of microvolt-level T-wave alternans provides clinical and prognostic value in nonischemic dilated cardiomyopathy. J Am Coll Cardiol. 2002;39:295–300
  4. Hohnloser SH, Ikeda T, Bloomfield DM, et al. T-wave alternans negative coronary patients with low ejection and benefit from defibrillator implantation. Lancet. 2003;362:125–126
  5. Bloomfield DM, Bigger JT, Steinman RC, et al. Microvolt T-wave alternans and the risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction. J Am Coll Cardiol. 2006;47:456–463
  6. Ikeda T, Yoshino H, Sugi K, et al. Predictive value of microvolt T-wave alternans for sudden cardiac death in patients with preserved cardiac function after acute myocardial infarction: results of a collaborative cohort study. J Am Coll Cardiol. 2006;48:2268–2274
  7. Salerno-Uriarte JA, De Ferrari GM, Klersy C, et al. Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy: results of the ALPHA Study. J Am Coll Cardiol. 2007;50:1896–1904
  8. Armoundas AA, Hohnloser SH, Ikeda T, et al. Can microvolt T-wave alternans testing reduce unnecessary defibrillator implantation?. Nat Clin Pract Cardiovasc Med. 2005;2:522–528
  9. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877–883
  10. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225–237
  11. Cantillon DJ, Stein KM, Markowitz SM, et al. Predictive value of microvolt T-wave alternans in patients with left ventricular dysfunction. J Am Coll Cardiol. 2007;50:166–173
  12. Chow T, Kereiakes DJ, Bartone C, et al. Prognostic utility of microvolt T-wave alternans in risk stratification of patients with ischemic cardiomyopathy. J Am Coll Cardiol. 2006;47:1820–1827
  13. Chow T, Kereiakes DJ, Onufer J, et al. Late-breaking clinical trials abstract: primary results from the Microvolt T Wave Alternans Testing for Risk Stratification of Post MI Patients (MASTER I) trial. Circulation. 2007;116:2631
  14. Costantini O, Rosenbaum DS, Hohnloser SH, et al. Late-breaking clinical trials abstract: the Alternans Before Cardioverter Defibrillator (ABCD) trial: a noninvasive strategy for primary prevention of sudden cardiac death using T-wave alternans. Circulation. 2006;114:2426
  15. Gold MR, Ensley D, Chilson D, et al. T-wave alternans SCD HeFT study: primary end point analysis. Circulation. 2006;114:II_428–II_429(abstr 2113)
  16. Ellenbogen KA, Levine JH, Berger RD, et al. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy?. Circulation. 2006;113:776–782
  17. Germano JJ, Reynolds M, Essebag V, et al. Frequency and causes of implantable cardioverter-defibrillator therapies: is device therapy proarrhythmic?. Am J Cardiol. 2006;97:1255–1261
  18. Connolly SJ. Use and misuse of surrogate outcomes in arrhythmia trials. Circulation. 2006;113:764–766
  19. Bloomfield DM, Steinman RC, Namerow PB, et al. Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: a solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum. Circulation. 2004;110:1885–1889
  20. Daubert JP, Wilber DJ, Lin A, et al. ICD therapy for fast ventricular tachycardia or ventricular fibrillation is a surrogate end point for mortality in MADIT II. Circulation. 2003;108:1786
  21. Grimm W, Christ M, Bach J, et al. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg cardiomyopathy study. Circulation. 2003;108:2883–2891
  22. Klingenheben T, Gronefeld G, Li YG, et al. Effect of metoprolol and d,l-sotalol on microvolt-level T-wave alternans (Results of a prospective, double-blind, randomized study). J Am Coll Cardiol. 2001;38:2013–2019
  23. Murata M, Harada M, Shimizu A, et al. Effect of long-term beta-blocker therapy on microvolt-level T-wave alternans in association with the improvement of the cardiac sympathetic nervous system and systolic function in patients with non-ischemic heart disease. Circ J. 2003;67:821–825
  24. Reynolds MR, Cohen DJ, Kugelmass AD, et al. The frequency and incremental cost of major complications among Medicare beneficiaries receiving implantable cardioverter-defibrillators. J Am Coll Cardiol. 2006;47:2493–2497
  25. Alter P, Waldhans S, Plachta E, et al. Complications of implantable cardioverter defibrillator therapy in 440 consecutive patients. Pacing Clin Electrophysiol. 2005;28:926–932
  26. Hohnloser SH, Kuck KH, Dorian P, et al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med. 2004;351:2481–2488
  27. Chow T, Kereiakes DJ, Bartone C, et al. Microvolt T-wave alternans identifies patients with ischemic cardiomyopathy who benefit from implantable cardioverter-defibrillator therapy. J Am Coll Cardiol. 2007;49:50–58
  28. Rosamond W, Flegal K, Friday G, et al. Heart disease and stroke statistics—2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2007;115:e69–e171
  29. Solomon SD, Anavekar N, Skali H, et al. Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients. Circulation. 2005;112:3738–3744
  30. Exner DV, Kavanagh KM, Slawnych MP, et al. Noninvasive risk assessment early after a myocardial infarction. J Am Coll Cardiol. 2007;50:2275–2284
  31. Stecker EC, Vickers C, Waltz J, et al. Population-based analysis of sudden cardiac death with and without left ventricular systolic dysfunction: two-year findings from the Oregon Sudden Unexpected Death Study. J Am Coll Cardiol. 2006;47:1161–1166
  32. Kaufman ES, Bloomfield DM, Steinman RC, et al. “Indeterminate” microvolt T-wave alternans tests predict high risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction. J Am Coll Cardiol. 2006;48:1399–1404
  33. Moss AJ, Greenberg H, Case RB, et al. Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator. Circulation. 2004;110:3760–3765

 Dr. Hohnloser has research grant, consultancy, and speaker's bureau associations with St. Jude Medical and Sanofi Aventis. The MTWA technology was developed in Dr. Cohen's laboratory at the Massachusetts Institute of Technology (MIT). MIT licensed the technology to Cambridge Heart, Inc. Dr. Cohen has a financial involvement with Cambridge Heart as a consequence of the original licensure of the technology and his ongoing service as a consultant, director, and speaker's bureau member. Dr. Cohen has been a consultant to Medtronic, Inc. Dr Takanori Ikeda has no conflict of interest.

PII: S1547-5271(08)00978-8

doi: 10.1016/j.hrthm.2008.10.011

Heart Rhythm
Volume 6, Issue 3, Supplement , Pages S36-S44 , March 2009

Article Tools

* Image Usage & Resolution